Algert Global’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30K | Sell |
4,053
-1,348
| -25% | -$9.98K | ﹤0.01% | 1167 |
|
|
2025
Q1 | $46K | Buy |
5,401
+2,998
| +125% | +$25.5K | ﹤0.01% | 1154 |
|
|
2024
Q4 | $86K | Sell |
2,403
-136
| -5% | -$4.87K | ﹤0.01% | 1129 |
|
|
2024
Q3 | $120K | Buy |
2,539
+753
| +42% | +$35.6K | ﹤0.01% | 1101 |
|
|
2024
Q2 | $90K | Buy |
+1,786
| New | +$90K | ﹤0.01% | 1402 |
|
|
2023
Q3 | – | Sell |
-8,794
| Closed | -$723K | – | 1203 |
|
|
2023
Q2 | $723K | Buy |
8,794
+7,540
| +601% | +$620K | 0.03% | 730 |
|
|
2023
Q1 | $129K | Sell |
1,254
-1,092
| -47% | -$112K | 0.01% | 1069 |
|
|
2022
Q4 | $344K | Hold |
2,346
| – | – | 0.02% | 905 |
|
|
2022
Q3 | $397K | Buy |
+2,346
| New | +$397K | 0.02% | 873 |
|
|
2022
Q1 | – | Sell |
-1,004
| Closed | -$156K | – | 1263 |
|
|
2021
Q4 | $156K | Buy |
1,004
+288
| +40% | +$44.7K | 0.02% | 885 |
|
|
2021
Q3 | $169K | Buy |
+716
| New | +$169K | 0.02% | 935 |
|
|
2021
Q1 | – | Sell |
-372
| Closed | -$248K | – | 494 |
|
|
2020
Q4 | $248K | Buy |
+372
| New | +$248K | 0.07% | 324 |
|
|
2020
Q3 | – | Sell |
-1,362
| Closed | -$797K | – | 455 |
|
|
2020
Q2 | $797K | Sell |
1,362
-313
| -19% | -$183K | 0.27% | 134 |
|
|
2020
Q1 | $244K | Sell |
1,675
-406
| -20% | -$59.1K | 0.1% | 281 |
|
|
2019
Q4 | $298K | Buy |
2,081
+532
| +34% | +$76.2K | 0.09% | 265 |
|
|
2019
Q3 | $61K | Hold |
1,549
| – | – | 0.02% | 339 |
|
|
2019
Q2 | $157K | Buy |
1,549
+712
| +85% | +$72.2K | 0.06% | 299 |
|
|
2019
Q1 | $110K | Buy |
+837
| New | +$110K | 0.06% | 276 |
|